13F filing recap · Q2 2013
What did Viking Global Investors buy in Q2 2013?
Reported stock-position changes between this filing and the previous one.
Stock value
$18.00B
Positions
59
Estimated turnover
58.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
TMOThermo Fisher Scientific Inc.$735.40Mreported value+8.69M sharesNWSANews Corporation$398.12Mreported value+12.22M sharesDGDollar General Corp$216.57Mreported value+4.29M sharesACTActavis Inc$179.20Mreported value+1.42M sharesMETMetlife, Inc.$178.11Mreported value+3.89M sharesPCLNBooking Holdings Inc$176.97Mreported value+214.1K sharesTGITriumph Group Inc$162.86Mreported value+2.06M sharesMHFIS&P Global Inc.$133.86Mreported value+2.52M sharesMUMicron Technology, Inc.$106.92Mreported value+7.46M sharesHUMHumana Inc$85.02Mreported value+1.01M sharesCSCOCisco Systems, Inc.$69.53Mreported value+2.86M sharesSHPGShire Plc$65.91Mreported value+693.0K sharesGILDGilead Sciences, Inc.$47.66Mreported value+929.5K sharesAAPLApple Inc.$44.49Mreported value+112.2K sharesTWCTime Warner Cable Inc$34.82Mreported value+309.6K sharesDISHDish Network Corporation$27.25Mreported value+641.0K sharesAGNCAgnc Investment Corp.$24.65Mreported value+1.07M sharesVARVarian Medical Systems, Inc.$21.42Mreported value+317.6K sharesRFRegions Financial Corporation$19.53Mreported value+2.05M sharesDHID.r. Horton, Inc.$13.24Mreported value+622.0K sharesAEGRAegerion Pharmaceuticals Inc$2.28Mreported value+36.0K shares